Statement Of Cash Flows [Abstract]

Exosens - Filing #5981339

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Increase (decrease) in working capital
9 510 EUR
21 667 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from non-current borrowings
250 000 EUR
65 000 EUR
Repayments of non-current borrowings
307 647 EUR
0 EUR
Proceeds from current borrowings
177,000 EUR
82,000 EUR
Repayments of current borrowings
4 841 EUR
5 401 EUR
Payments for share issue costs
7 801 EUR
0 EUR
Payments for debt issue costs
6 955 EUR
1 752 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.